Cargando…
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 has spread rapidly worldwide and has been shown to have a wide spectrum of severity. COVID-19 has become a public health emergency of...
Autores principales: | Torres, Tiago, Puig, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147535/ https://www.ncbi.nlm.nih.gov/pubmed/32277351 http://dx.doi.org/10.1007/s40257-020-00514-2 |
Ejemplares similares
-
Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
por: Jacobson, Sheldon H., et al.
Publicado: (2021) -
Optimizing the trauma resuscitation bay during the covid-19 pandemic
por: Livingston, David Hugh, et al.
Publicado: (2020) -
Paradigm shift of drug information centers during the COVID-19 pandemic
por: Khatiwada, Asmita Priyadarshini, et al.
Publicado: (2020) -
Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic
por: Shurlock, Jonathan, et al.
Publicado: (2021) -
Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide
por: Kow, Chia Siang, et al.
Publicado: (2020)